
Ep. 201: Joe Fahmy: Tight Is Right
Investing With IBD
XBI's Potential in the Biotech Market
XBI has a product that not only is a better solution as far as the chemistry of it but it lasts longer than Botox where Botox is about three four months their solution last four to six months. The reason for the big jump recently is they weren't expecting any sales and they surprised with about eleven or twelve billion in sales when they weren't expected any. I kind of I kind of give XBI for that reason because I completely understand and respect people don't want the risk they don't want. They might they might not understand certain things either so when there's so many biotechs looking good it gives you broad exposure to it.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.